The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris

Journal of Dermatological Treatment

Volumn 18, Issue 5, 2007, Pages 275-278

  Momeni, Ali Z ^a,b   Iraji, Fariba ^a   Aminjavaheri, Malih ^a   Emami, Mahamd Reza ^a   Momeni, Amir ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Cyclophosphamide; Dexamethasone; Pemphigus; Pemphigus vulgaris; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE;

ADULT; AGED; ALOPECIA; AMENORRHEA; ARTICLE; CONTROLLED STUDY; CUSHINGOID SYNDROME; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; EDEMA; FEMALE; HAIR LOSS; HEALING; HEMORRHAGIC CYSTITIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEOPLASM; NEUTROPENIA; OSTEOPOROSIS; PANCYTOPENIA; PEMPHIGUS VULGARIS; PEPTIC ULCER; PRIORITY JOURNAL; REMISSION; SEX RATIO; SIDE EFFECT; STRIA; THRUSH; TREATMENT OUTCOME; WEIGHT GAIN;

ADMINISTRATION, ORAL; ADULT; AGED; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PEMPHIGUS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 35148877330     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701449080     Document Type: Article

References (25)

1. Korman NJ. Pemphigus. Dermatol Clin. 1990;8:689-700.
2. Tallab T, Joharji H, Bahamdan K, Karkashan E, Morad M, Ibrahim K. The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol. 2001;40:570-2.
3. Tsankov N, Vassileva S, Kamarashev J, Kazandjieva J, Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria. A 16-year retrospective study (1980-1995). Int J Dermatol. 2000;39:104-8.
4. Chams S, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, et al. Pemphigus: Analysis of 1209 cases. Int J Dermatol. 2005;44:470-6.
5. Lever WF, Schaumburg-Lever G. Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol. 1984;120:44-7.
6. Ahmed AR, Graham J, Jordon R, Provost T. Pemphigus: Current concepts. Ann Int Med. 1980;92:396-405.
7. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol. 1996;34:645-52.
8. Lever WF, Schaumburg-lever G. Immunosuppressants and prednisone in pemphigus vulgaris: Therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol. 1977;113:1236-41.
9. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus, an update. Arch Dermatol. 1996;132:203-12.
10. Werth VP. Treatment of pemphigus vulgaris with brief, high dose intravenous glucocorticoids. Arch Dermatol. 1996;132:1435-9.
11. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999;354:667-72.
12. Roujeau J. Pulse glucocorticoid therapy, the big shot revisited. Arch Dermatol. 1996;132:1499-502.
13. Pasrischa JS, Khaitan BK, Raman S, Chadra M. Dexamethasone- cyclophosphamide pulse therapy for pemphigus. Int J Dermatol. 1995;34:875-82.
14. Kanwar AJ, Dhar S. Factors responsible for death in patients with pemphigus. J Dermatol. 1994;21:655-9.
15. Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol. 1982;7:221-8.
16. Gallant C, Kenny P. Oral glucocorticoids and their complications; a review. J Am Acad Dermatol. 1986;14:161-77.
17. Toth GG, Kloosterman C, Uges DR, Jonkman MF. Pharmacokinetics of high-dose oral and intravenous dexamethasone. Ther Drug Monit. 1999;21:532-5.
18. Hayag MV, Cohen JA, Kerdel FA. Immunoablative high dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol. 2000;43:1065-9.
19. Euler HH, Loffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol. 1987;123:1205-10.
20. Ahmed AR, Hombal S. Use of cyclophosphamide in azathioprine failures in pemphigus. J Am Acad Dermatol. 1987;17:437-42.
21. Cummins DL, Mimouni D, Anhalt GJ, Nousari CH. Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus. J Am Acad Dermatol. 2003;49:267-80.
22. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol. 1999;135:57-61.
23. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol. 1990;29:371-4.
24. Fellner MJ, Katz JM, McCabe JB. Successful treatment of cyclophosphamide and prednisolone for initial treatment of pemphigus vulgaris. Arch Dermatol. 1978;114:889-94.
25. Kumrah L, Ramam M, Shah P, Pandey RM, Pasrichia JS. Pituitary-adrenal function - following dexamethasone-cyclophosphamide pulse therapy for pemphigus. Br J Dermatol. 2001;145:944-8.